モンテルカストナトリウムの市場規模、シェア、成長分析：製品タイプ別、剤形別、薬剤クラス別、用途別、流通チャネル別、地域別 - 産業予測 2025～2032年

モンテルカストナトリウムの世界市場規模は、2023年に4億5,820万米ドルと評価され、2024年の5億2,739万米ドルから2032年には16億2,455万米ドルに成長し、予測期間（2025～2032年）のCAGRは15.1％で成長する見通しです。

世界のモンテルカストナトリウム市場は、特に日本、ドイツ、イタリアなどの地域で、大気汚染の増加や高齢者人口の増加に起因する喘息やアレルギー性鼻炎の症例の増加によって大きな成長を遂げています。ヘルスケアのインフラが改善し、モンテルカストが治療ガイドラインに組み込まれるにつれて、この医薬品に対する需要は増加の一途をたどっています。製剤や併用療法における技術革新により、モンテルカストの有用性はさらに拡大しています。さらに、人工知能、IoT、ブロックチェーンなどの技術の進歩により、創薬の強化、適切な保管の確保、サプライチェーンの完全性の維持など、医薬品セクターの変革が進んでいます。これらの動向は、世界的に慢性呼吸器疾患が増加する中、モンテルカストナトリウム市場の持続的成長を位置づけています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析
• ケーススタディ

モンテルカストナトリウム市場規模：製品タイプ別

• 市場概要
• 吸入器
  • 乾燥粉末
  • 定量噴霧式
  • ソフトミスト
• ネブライザー

モンテルカストナトリウム市場規模：剤形別

• 市場概要
• タブレット
• 経口溶液
• その他

モンテルカストナトリウム市場規模：薬剤クラス別

• 市場概要
• 抗炎症
• 気管支拡張薬
• 併用療法

モンテルカストナトリウム市場規模：用途別

• 市場概要
• 喘息
• アレルギー性鼻炎
• 蕁麻疹
• その他の用途

モンテルカストナトリウム市場規模：流通チャネル別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

モンテルカストナトリウム市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Teva Pharmaceuticals USA Inc.（U.S.）
• Merck & Co. Inc.（U.S.）
• Cipla Limited（India）
• Morepen Laboratories（India）
• Sanofi Aventis SA（France）
• SUN PHARMA（India）
• Intas Pharmaceuticals Ltd（India）
• Delmar Chemicals Inc.（Canada）
• SK Capital（Apotex Inc）（Canada）
• Sanyo Chemical Industries Ltd（Japan）

結論と提言

Global Montelukast Sodium Market size was valued at USD 458.2 million in 2023 and is poised to grow from USD 527.39 million in 2024 to USD 1624.55 million by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The global montelukast sodium market is experiencing significant growth driven by a rise in asthma and allergic rhinitis cases, stemming from increasing air pollution and a growing elderly population, particularly in regions like Japan, Germany, and Italy. As healthcare infrastructure improves and montelukast is incorporated into treatment guidelines, demand for this medication continues to rise. Innovations in drug formulations and combination therapies are further expanding its usability. Additionally, advancements in technology, such as artificial intelligence, IoT, and blockchain, are transforming the pharmaceutical sector by enhancing drug discovery, ensuring proper storage, and maintaining supply chain integrity. These trends position the montelukast sodium market for sustained growth amid rising chronic respiratory issues globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Montelukast Sodium market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Montelukast Sodium Market Segments Analysis

Global Montelukast Sodium Market is segmented by Product Type, Dosage Form, Drug Class, Application, Distribution Channel and region. Based on Product Type, the market is segmented into Inhalers and Nebulizers. Based on Dosage Form, the market is segmented into Tablets, Oral solutions and Others. Based on Drug Class, the market is segmented into Anti-inflammatory, Bronchodilators and Combination Therapy. Based on Application, the market is segmented into Asthma, Allergic rhinitis, Urticaria and Other applications. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is being propelled by the rising incidence of respiratory disorders like asthma and allergic rhinitis, driven by various factors including air pollution, smoking, genetic factors, and shifts in lifestyle. As more people are diagnosed with chronic respiratory conditions linked to escalating air pollution, urbanization, climate change, and hereditary predispositions, there is a notable increase in demand for montelukast sodium. This growing recognition of the need for effective treatment options reflects the broader health trends and challenges contemporary societies face, ultimately contributing to the expansion of the montelukast sodium market on a global scale.

Restraints in the Global Montelukast Sodium Market

The global Montelukast Sodium market faces significant restraints due to the absence of patent protection, resulting in heightened competition among manufacturers. The presence of generic versions of Montelukast Sodium, often available at lower prices, adversely affects the sales of branded products. Additionally, the influx of inexpensive imported montelukast sodium further hampers the growth of domestic markets, making it challenging for local producers to compete effectively. This intense rivalry and price undercutting create a competitive landscape that restricts the potential expansion opportunities for established brands within the Montelukast Sodium sector, leading to a constrained market environment overall.

Market Trends of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is witnessing a significant trend driven by patent expirations, leading to a surge in generic formulations that provide equivalent therapeutic benefits at reduced prices. This shift is favored by patients, healthcare practitioners, and government health systems seeking cost-effective treatment options. As more pharmaceutical companies enter the market, increased competition is fostering innovation and accessibility in montelukast sodium products. Meanwhile, regulatory authorities continue to implement stringent approval processes for generics, ensuring safety and efficacy. This multifaceted landscape is reshaping the market dynamics, ultimately benefiting end-users while expanding the global reach of montelukast sodium.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Montelukast Sodium Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhalers
  • Dry Powder
  • Metered Dose
  • Soft Mist
• Nebulizers

Global Montelukast Sodium Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Tablets
• Oral solutions
• Others

Global Montelukast Sodium Market Size by Drug Class & CAGR (2025-2032)

• Market Overview
• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Global Montelukast Sodium Market Size by Application & CAGR (2025-2032)

• Market Overview
• Asthma
• Allergic rhinitis
• Urticaria
• Other applications

Global Montelukast Sodium Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Global Montelukast Sodium Market Size & CAGR (2025-2032)

• North America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceuticals USA Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morepen Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Aventis SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SUN PHARMA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delmar Chemicals Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Capital (Apotex Inc) (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanyo Chemical Industries Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations